-inc-logo-1200x675.png){kind=logo}
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $8.36, but opened at $8.95. WuXi Biologics (Cayman) shares last traded at $8.5650, with a volume of 929 shares traded.
WuXi Biologics (Cayman) Stock Performance
The business’s 50-day moving average price is $8.78 and its 200 day moving average price is $9.01.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
